Extracellular matrix cues regulate mechanosensing and mechanotransduction of cancer cells

CT Mierke - Cells, 2024 - mdpi.com
Extracellular biophysical properties have particular implications for a wide spectrum of
cellular behaviors and functions, including growth, motility, differentiation, apoptosis, gene …

Switch-independent 3A: an epigenetic regulator in cancer with new implications for pulmonary arterial hypertension

K Jankowski, V Jagana, M Bisserier, L Hadri - Biomedicines, 2023 - mdpi.com
Epigenetic mechanisms, including DNA methylation, histone modifications, and non-coding
RNA, play a crucial role in the regulation of gene expression and are pivotal in biological …

Salt-inducible kinases: new players in pulmonary arterial hypertension?

T António, P Soares-da-Silva, NM Pires… - Trends in …, 2022 - cell.com
Salt-inducible kinases (SIKs) are serine/threonine kinases belonging to the AMP-activated
protein kinase (AMPK) family. Accumulating evidence indicates that SIKs phosphorylate …

Sanguinarine Reverses Pulmonary Vascular Remolding of Hypoxia-Induced PH via Survivin/HIF1α-Attenuating Kv Channels

F Fan, Y Zou, Y Wang, P Zhang, X Wang… - Frontiers in …, 2021 - frontiersin.org
Background: Similarities in the biology of pulmonary hypertension and cancer suggest that
anticancer therapies, such as sanguinarine, may also be effective in treating pulmonary …

[HTML][HTML] Interplay of Transcriptomic Regulation, Microbiota, and Signaling Pathways in Lung and Gut Inflammation-Induced Tumorigenesis

BA Otálora-Otálora, C Payán-Gómez, JJ López-Rivera… - Cells, 2024 - mdpi.com
Inflammation can positively and negatively affect tumorigenesis based on the duration,
scope, and sequence of related events through the regulation of signaling pathways. A …

Death-associated protein kinase 1 prevents hypoxia-induced metabolic shift and pulmonary arterial smooth muscle cell proliferation in PAH

LM Seidel, J Thudium, C Smith, V Sapehia, N Sommer… - Cellular …, 2025 - Elsevier
Pulmonary hypertension (PH) is a general term used to describe high blood pressure in the
lungs from any cause. Pulmonary arterial hypertension (PAH) is a progressive, and fatal …

[HTML][HTML] The diverging roles of insulin-like growth factor binding proteins in pulmonary arterial hypertension

BC Schlueter, K Quanz, J Baldauf, A Petrovic… - Vascular …, 2024 - Elsevier
Pulmonary hypertension (PH) is a progressive, severe and to date not curable disease of the
pulmonary vasculature. Alterations of the insulin-like growth factor 1 (IGF-1) system are …

Use of combined chemotherapy and immunotherapy improves pulmonary arterial hypertension

TP Reddy, R Barrios, E Bernicker, W Qian… - Pulmonary …, 2024 - Wiley Online Library
Abstract Treatment modalities for pulmonary arterial hypertension (PAH) improve quality of
life and walk distance. However, none of these therapies alter the structural/functional …

[HTML][HTML] The lamp of medicine of Ancient Egypt is still burning

G Butrous, B Maron, M Yacoub - Global cardiology science & …, 2020 - ncbi.nlm.nih.gov
In the land of Ancient Egypt, where the Pharaonic civilization flourished, one can encounter
sophisticated methods of treating human illnesses. The Ancient Egyptians considered a …

[HTML][HTML] The therapeutic effect and mechanism of Rapamycin combined with HO-3867 on monocrotaline-induced pulmonary hypertension in rats

H Peng, L Zhou, H Li, Y Zhang, S Cheng… - European Journal of …, 2022 - Elsevier
This study test was designed to investigate the possible modulatory effect of rapamycin
combined with HO-3867 in monocrotaline (MCT)-induced pulmonary arterial hypertension in …